source
- FDA grants Capricor three-month extension to review DMD cell therapy dataThe U.S. Food and Drug Administration has given Capricor Therapeutics an additional three months to evaluate its Duchenne muscular dystrophy cell therapy after the agency asked for more information…
- How Trump’s cuts are reshaping America’s health systemA scramble to prepare for massive federal cuts across the health care system is hitting rural states like Maine particularly hard.STAT · 52m ago↗ source